Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study

OBJECTIVE: To assess the efficacy of recombinant human erythropoietin (rhEPO) in amyotrophic lateral sclerosis (ALS). METHODS: Patients with probable laboratory-supported, probable or definite ALS were enrolled by 25 Italian centres and randomly assigned (1:1) to receive intravenous rhEPO 40 000 IU...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurol Neurosurg Psychiatry
Main Authors: Lauria, Giuseppe, Dalla Bella, Eleonora, Antonini, Giovanni, Borghero, Giuseppe, Capasso, Margherita, Caponnetto, Claudia, Chiò, Adriano, Corbo, Massimo, Eleopra, Roberto, Fazio, Raffaella, Filosto, Massimiliano, Giannini, Fabio, Granieri, Enrico, La Bella, Vincenzo, Logroscino, Giancarlo, Mandrioli, Jessica, Mazzini, Letizia, Monsurrò, Maria Rosaria, Mora, Gabriele, Pietrini, Vladimiro, Quatrale, Rocco, Rizzi, Romana, Salvi, Fabrizio, Siciliano, Gabriele, Sorarù, Gianni, Volanti, Paolo, Tramacere, Irene, Filippini, Graziella
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2015
Assuntos:
Neuromuscular
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4515982/
https://ncbi.nlm.nih.gov/pubmed/25595151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2014-308996
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados